Lupin Secures USFDA Nod for Liraglutide and Glucagon, Expands Diabetes and Emergency Care Portfolio

Unknown Apr 02, 2026 1,000 Views

Lupin Ltd has received tentative approval from the US Food and Drug Administration (USFDA) for its generic formulations of Liraglutide and Glucagon, marking a strategic leap in its diabetes and emergency medicine offerings. Key Highlights - Liraglutide, a GLP-1 receptor ago...